• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea

    PR NEWSWIRE

    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi

    PR NEWSWIRE

    Orasis Pharma Completes $78 Million Financing to Launch Qlosia

    PR NEWSWIRE

    Orasis gains FDA approval for presbyopia eye drops

    PR NEWSWIRE

    Orasis Announces Ph2b Trial Efficacy and Safety Results of Novel Eye Drop

    PRNEWSWIRE

    Orasis will ship its Vuity eye drop competitor to the FDA later this year

    ENDPTS

    Orasis Pharmaceuticals Announces Positive Phase 3 Topline Results of Novel Eye Drop Candidate, CSF-1, for the Treatment of Presbyopia

    PRNEWSWIRE

    Orasis Pharma to Present New Data on Novel Presbyopia Candidate at 2022 ASCRS

    PRNEWSWIRE

    Orasis Pharma Concludes P 3 Trials for Presbyopia Candidate

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.